A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases

Clinical trial NCT07583030 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07583030
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE)Relapsed/Refractory IgG4-Related Disease (r/r IgG4-RD)Progressive Multiple Sclerosis (PMS)Relapsed/Refractory Myasthenia Gravis(r/r MS)

Start date: 2026-04-20
Primary completion: 2028-09-20
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.